Pulse Biosciences, Inc. Repayments of Related Party Debt
Pulse Biosciences, Inc. (PLSE) reported Repayments of Related Party Debt of $0 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2024-08-19
- Pulse Biosciences, Inc. repayments of related party debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. repayments of related party debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. repayments of related party debt for the quarter ending 2023-06-30 was $828.00K.
- Pulse Biosciences, Inc. repayments of related party debt for the quarter ending 2023-03-31 was $917.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month |
|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $0.00 10-Q · filed 2024-08-19 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | |
| 2023-06-30 | $828.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $1.75M 10-Q · filed 2024-08-19 |
| 2023-03-31 | $917.00K 10-Q · filed 2024-05-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |